Multipeptide Vaccine AML-VAC-XS15(University Of Tubingen)

N/A

Report date: 2024/03/28 20:00:34

Base Information

Drug NameMultipeptide Vaccine AML-VAC-XS15(University Of Tubingen)
Drug Alias NameMulti-peptide Vaccination Adjuvanted With XS15(University Of Tubingen)AML-VAC-XS15
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospital Tuebingen
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A